期刊文献+

不同剂量他汀类药物对冠心病并发高脂血症患者的血脂及血管内皮功能的影响 被引量:3

Effect of different dosages of statins on blood lipid and vascular endothelial function in patients with coronary disease combined hyperlipidemia
暂未订购
导出
摘要 ①目的探讨不同剂量他汀类药物对冠心病并发高脂血症患者的血脂及血管内皮功能的影响。②方法选择冠心病并发高脂血症患者200例,随机分为4组,分别服用辛伐他汀10mg、20mg;阿托伐他汀10mg、20mg,4周后分别检测血脂水平、血管内皮功能的变化。③结果辛伐他汀、阿托伐他汀治疗4周后,可有效降低冠心病并发高脂血症患者的TC、TG、LDL-c水平,并改善血管内皮功能(NO升高,ET水平降低),差异具有显著性,在同种药物中20mg组优于10mg组,差异显著(P<0.05)。④结论阿托伐他汀、辛伐他汀通过有效降低冠心病并发高脂血症患者的TC、TG、LDL-c水平,改善血管内皮功能,而且与剂量有关。 Objective To observe the effcacy of the different dosage of simvastatin and atrovastain on blood lipid level and vascular endothelial function in patients with coronary heart disease combined hyperlipidcmia. Methods Two hundred patients with coronary disease combined hyperlipidemia were divided randomly into 4 groups and took medicine: simvastatin 10mg group, 20mg group and atorvastain 10mg group,20mg group. Blood lipid level and vascular endothelial function were detected after 4 weeks. Results Levels of LDL - c,TC and TG were reduced efficiently and vascular endothelial function was improved by simvastain and atorvastain in patients with coronary disease combined hyperlipidemia after 4 weeks ( P 〈 0.05 ), while the effect in atorvastain group was better than that in the simvastatin group ,but there was no significant difference in the same dosage ( P 〉 0.05). The effect of 20mg group were significantly better than that of 10mg group in the same medicine ( P 〈 0.05 ). Conclusions Simvastain and atorvastain could predominantly decrease the level of TC ,TG,LDL - c and improve endothelial function in patients with coronary disease combined hyperlipidemia and regarded as common drug in coronary heart disease treatment.
作者 刘伟 潘茗
出处 《华北煤炭医学院学报》 2008年第6期747-748,共2页 Journal of North China Coal Medical College
关键词 冠心病 高脂血症 他汀类降脂药 血管内皮功能 Coronary disease. Hyperlipidemia. Statins. Vascular endothelial function
  • 相关文献

参考文献6

  • 1Ito MK,Talbert RL , Tsimikas S. Statin - associated pleiotropy : possible beneficial effects beyond cholesterol reduction [ J ]. Pharmacotherapy,2006,26 (7Pt2) :85.
  • 2方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3069
  • 3徐亚平,陈文肖.阿托伐他汀治疗老年高胆固醇血症患者对胰岛素抵抗的影响[J].中华老年医学杂志,2003,22(4):247-247. 被引量:83
  • 4Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor [ J ]. Am J Cardiol,2000,86 (9) : 943.
  • 5Puccetti L, Pasqui AL, Pastorelli M, et al. Platelet hyperactivity after statin treatment diseontinuation [ J ]. Thromb Haemost, 2003,90 ( 3 ) : 476.
  • 6Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease:from marvel to menace[J]. Circulation,2006,113 (13) :1708.

二级参考文献3

共引文献3131

同被引文献29

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部